Colin Wilde, PhD
Colin Wilde, PhD, co-founded AvantiCell Science Limited (ACS) in 2006 and serves as its Chief Scientific Officer and Executive Director. Dr. Wilde trained as a biochemist and has published more than 100 research papers in the field of biochemistry/cell biology; he is a named inventor on ten patents or patent applications in related fields. Colin leads AvantiCell’s commercial science business and oversees its programme of technical innovation in the field of cell-based analysis, which has secured >€10M in public funding support. He is also a co-founder and Executive Director of AvantiCell AsiaPacific Sdn Bhd, a Malaysian wholly-owned ACS subsidiary.